Triptolide induces suppressor of cytokine signaling-3 expression and promotes lamina propria mononuclear cells apoptosis in Crohn's colitis.

[1]  Ning Li,et al.  Triptolide ameliorates Crohn's colitis is associated with inhibition of TLRs/NF-κB signaling pathway. , 2011, Fitoterapia.

[2]  W. Strober,et al.  Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. , 2011, Gastroenterology.

[3]  Jie-shou Li,et al.  Triptolide ameliorates IL-10-deficient mice colitis by mechanisms involving suppression of IL-6/STAT3 signaling pathway and down-regulation of IL-17. , 2010, Molecular immunology.

[4]  Weiming Zhu,et al.  Therapeutic effects of triptolide on interleukin-10 gene-deficient mice with colitis. , 2008, International immunopharmacology.

[5]  Jie-shou Li,et al.  The suppressive effect of triptolide on chronic colitis and TNF-alpha/TNFR2 signal pathway in interleukin-10 deficient mice. , 2008, Clinical immunology.

[6]  R. Rottapel,et al.  Putting out the fire: coordinated suppression of the innate and adaptive immune systems by SOCS1 and SOCS3 proteins , 2008, Immunological reviews.

[7]  Toshio Hirano,et al.  IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state. , 2007, International immunology.

[8]  L. Hennighausen,et al.  Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[9]  H. Weiner,et al.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells , 2006, Nature.

[10]  Laurent Beaugerie,et al.  The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis. , 2006, Journal of Crohn's & colitis.

[11]  X. Mao,et al.  Triptolide affects the differentiation, maturation and function of human dendritic cells. , 2005, International immunopharmacology.

[12]  P. Dentelli,et al.  Signal Transducers and Activators of Transcription 3 Signaling Pathway: An Essential Mediator of Inflammatory Bowel Disease and Other Forms of Intestinal Inflammation , 2005, Inflammatory bowel diseases.

[13]  R. Kiesslich,et al.  Activation Pattern of Signal Transducers and Activators of Transcription (STAT) Factors in Inflammatory Bowel Diseases , 2005, The American Journal of Gastroenterology.

[14]  David A. Frank,et al.  Genome-wide analysis of STAT target genes: Elucidating the mechanism of STAT-mediated oncogenesis , 2004, Cancer biology & therapy.

[15]  J. Jacobberger,et al.  Divergent cell cycle kinetics underlie the distinct functional capacity of mucosal T cells in Crohn’s disease and ulcerative colitis , 2004, Gut.

[16]  A. Yoshimura,et al.  Regulation of TLR signaling and inflammation by SOCS family proteins , 2004, Journal of leukocyte biology.

[17]  Roland Lang,et al.  SOCS3 regulates the plasticity of gp130 signaling , 2003, Nature Immunology.

[18]  S. Akira,et al.  Cis3/Socs3/Ssi3 Plays a Negative Regulatory Role in Stat3 Activation and Intestinal Inflammation , 2001, The Journal of experimental medicine.

[19]  A. Levine.  Apoptosis: Implications for inflammatory bowel disease , 2000 .

[20]  J. G. Zhang,et al.  Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[21]  M. Neurath,et al.  Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn disease and experimental colitis in vivo , 2000, Nature Medicine.

[22]  T. Hirano,et al.  Synergistic roles for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and antiapoptosis. , 1999, Immunity.

[23]  K. Madsen,et al.  Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. , 1999, Gastroenterology.

[24]  W. Gu,et al.  Inhibition of type II collagen-induced arthritis in rats by triptolide. , 1998, International journal of immunopharmacology.

[25]  Y. Yang,et al.  Triptolide induces apoptotic death of T lymphocyte. , 1998, Immunopharmacology.

[26]  C. Fiocchi.  Inflammatory bowel disease: etiology and pathogenesis. , 1998, Gastroenterology.

[27]  T. Hirano,et al.  Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis. , 1996, Immunity.

[28]  M. Leach,et al.  Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. , 1996, The Journal of clinical investigation.

[29]  M. Neurath,et al.  Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. , 1996, Journal of immunology.

[30]  M. Leach,et al.  T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice , 1996, The Journal of experimental medicine.

[31]  K. Rajewsky,et al.  Interleukin-10-deficient mice develop chronic enterocolitis , 1993, Cell.

[32]  D. Podolsky,et al.  Inflammatory bowel disease (1) , 1991, The New England journal of medicine.

[33]  Jie-shou Li,et al.  Triptolide suppresses IL-1β-induced chemokine and stromelysin-1 gene expression in human colonic subepithelial myofibroblasts , 2007, Acta Pharmacologica Sinica.

[34]  R. Blumberg,et al.  The immunology of mucosal models of inflammation. , 2002, Annual review of immunology.

[35]  J. Turkson,et al.  Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. , 1999, Immunity.